<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33149110</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2158-3188</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Nov</Month><Day>04</Day></PubDate></JournalIssue><Title>Translational psychiatry</Title><ISOAbbreviation>Transl Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Coexistence of perseveration and apathy in the TDP-43<sup>Q331K</sup> knock-in mouse model of ALS-FTD.</ArticleTitle><Pagination><StartPage>377</StartPage><MedlinePgn>377</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">377</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41398-020-01078-9</ELocationID><Abstract><AbstractText>Perseveration and apathy are two of the most common behavioural and psychological symptoms of dementia (BPSDs) in amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD). Availability of a validated and behaviourally characterised animal model is crucial for translational research into BPSD in the FTD context. We behaviourally evaluated the male TDP-43<sup>Q331K</sup> mouse, an ALS-FTD model with a human-equivalent mutation (TDP-43<sup>Q331K</sup>) knocked into the endogenous Tardbp gene. We utilised a panel of behavioural tasks delivered using the rodent touchscreen apparatus, including progressive ratio (PR), extinction and visual discrimination/reversal learning (VDR) assays to examine motivation, response inhibition and cognitive flexibility, respectively. Relative to WT littermates, TDP-43<sup>Q331K</sup> mice exhibited increased responding under a PR schedule. While elevated PR responding is typically an indication of increased motivation for reward, a trial-by-trial response rate analysis revealed that TDP-43<sup>Q331K</sup> mice exhibited decreased maximal response rate and slower response decay rate, suggestive of reduced motivation and a perseverative behavioural phenotype, respectively. In the extinction assay, TDP-43<sup>Q331K</sup> mice displayed increased omissions during the early phase of each session, consistent with a deficit in activational motivation. Finally, the VDR task revealed cognitive inflexibility, manifesting as stimulus-bound perseveration. Together, our data indicate that male TDP-43<sup>Q331K</sup> mice exhibit a perseverative phenotype with some evidence of apathy-like behaviour, similar to BPSDs observed in human ALS-FTD patients. The TDP-43<sup>Q331K</sup> knock-in mouse therefore has features that recommend it as a useful platform to facilitate translational research into behavioural symptoms in the context of ALS-FTD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Eosu</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-9472-9465</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Institute of Behavioral Science in Medicine, Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychology and MRC/Wellcome Trust Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>White</LastName><ForeName>Matthew A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phillips</LastName><ForeName>Benjamin U</ForeName><Initials>BU</Initials><AffiliationInfo><Affiliation>Department of Psychology and MRC/Wellcome Trust Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez-Cruz</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Psychology and MRC/Wellcome Trust Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Life, Health and Chemical Sciences, The Open University, Walton Hall, Milton Keynes, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hyunjeong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Institute of Behavioral Science in Medicine, Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychology and MRC/Wellcome Trust Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anatomy, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heath</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>School of Life, Health and Chemical Sciences, The Open University, Walton Hall, Milton Keynes, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jong Eun</ForeName><Initials>JE</Initials><Identifier Source="ORCID">0000-0001-6203-7413</Identifier><AffiliationInfo><Affiliation>Department of Anatomy, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saksida</LastName><ForeName>Lisa M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Psychology and MRC/Wellcome Trust Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Medicine Research Laboratories, Robarts Research Institute &amp; Department of Physiology and Pharmacology, Schulich School of Medicine &amp; Dentistry, Western University, London, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Brain and Mind Institute, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sreedharan</LastName><ForeName>Jemeen</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-8682-6844</Identifier><AffiliationInfo><Affiliation>Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. jemeen.sreedharan@kcl.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bussey</LastName><ForeName>Timothy J</ForeName><Initials>TJ</Initials><Identifier Source="ORCID">0000-0002-3180-3709</Identifier><AffiliationInfo><Affiliation>Department of Psychology and MRC/Wellcome Trust Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK. tbussey@uwo.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Medicine Research Laboratories, Robarts Research Institute &amp; Department of Physiology and Pharmacology, Schulich School of Medicine &amp; Dentistry, Western University, London, ON, Canada. tbussey@uwo.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Brain and Mind Institute, Western University, London, ON, Canada. tbussey@uwo.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>SREEDHARAN/JAN13/943-795</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>SREEDHARAN/APR16/849-791</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>NC/N001451/1</GrantID><Acronym>NC3RS_</Acronym><Agency>National Centre for the Replacement, Refinement and Reduction of Animals in Research</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>HI14C2173</GrantID><Agency>Ministry of Health and Welfare (Ministry of Health, Welfare and Family Affairs)</Agency><Country>International</Country></Grant><Grant><GrantID>MR/K010611/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Transl Psychiatry</MedlineTA><NlmUniqueID>101562664</NlmUniqueID><ISSNLinking>2158-3188</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C578077">TDP-43 protein, mouse</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C565957">Amyotrophic Lateral Sclerosis 2, Juvenile</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057565" MajorTopicYN="Y">Apathy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>5</Day><Hour>5</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33149110</ArticleId><ArticleId IdType="pmc">PMC7643138</ArticleId><ArticleId IdType="doi">10.1038/s41398-020-01078-9</ArticleId><ArticleId IdType="pii">10.1038/s41398-020-01078-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Boeve BF, et al. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain. 2012;135:765&#x2013;783. doi: 10.1093/brain/aws004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws004</ArticleId><ArticleId IdType="pmc">PMC3286335</ArticleId><ArticleId IdType="pubmed">22366793</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell JR, et al. The frontotemporal dementia-motor neuron disease continuum. Lancet. 2016;388:919&#x2013;931. doi: 10.1016/S0140-6736(16)00737-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)00737-6</ArticleId><ArticleId IdType="pubmed">26987909</ArticleId></ArticleIdList></Reference><Reference><Citation>de Vugt ME, et al. A prospective study of the effects of behavioral symptoms on the institutionalization of patients with dementia. Int. Psychogeriatr. 2005;17:577&#x2013;589. doi: 10.1017/S1041610205002292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610205002292</ArticleId><ArticleId IdType="pubmed">16185379</ArticleId></ArticleIdList></Reference><Reference><Citation>Masopust J, Protopopova D, Valis M, Pavelek Z, Klimova B. Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review. Neuropsychiatr. Dis. Treat. 2018;14:1211&#x2013;1220. doi: 10.2147/NDT.S163842.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NDT.S163842</ArticleId><ArticleId IdType="pmc">PMC5953267</ArticleId><ArticleId IdType="pubmed">29785112</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez MF, Lauterbach EC, Sampson SM. Research ACo. An evidence-based review of the psychopathology of frontotemporal dementia: a report of the ANPA Committee on Research. J. Neuropsychiatry Clin. Neurosci. 2008;20:130&#x2013;149. doi: 10.1176/jnp.2008.20.2.130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/jnp.2008.20.2.130</ArticleId><ArticleId IdType="pubmed">18451185</ArticleId></ArticleIdList></Reference><Reference><Citation>Raaphorst J, Beeldman E, De Visser M, De Haan RJ, Schmand B. A systematic review of behavioural changes in motor neuron disease. Amyotroph. Lateral Scler. 2012;13:493&#x2013;501. doi: 10.3109/17482968.2012.656652.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.656652</ArticleId><ArticleId IdType="pubmed">22424127</ArticleId></ArticleIdList></Reference><Reference><Citation>Lillo P, Mioshi E, Zoing MC, Kiernan MC, Hodges JR. How common are behavioural changes in amyotrophic lateral sclerosis? Amyotroph. Lateral Scler. 2011;12:45&#x2013;51. doi: 10.3109/17482968.2010.520718.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.520718</ArticleId><ArticleId IdType="pubmed">20849323</ArticleId></ArticleIdList></Reference><Reference><Citation>Radakovic R, et al. Multidimensional apathy in ALS: validation of the dimensional apathy scale. J. Neurol. Neurosurg. Psychiatry. 2016;87:663&#x2013;669. doi: 10.1136/jnnp-2015-310772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-310772</ArticleId><ArticleId IdType="pubmed">26203157</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolley SC, Zhang Y, Schuff N, Weiner MW, Katz JS. Neuroanatomical correlates of apathy in ALS using 4 Tesla diffusion tensor MRI. Amyotroph. Lateral Scler. 2011;12:52&#x2013;58. doi: 10.3109/17482968.2010.521842.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.521842</ArticleId><ArticleId IdType="pubmed">21271791</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Benajiba L, et al. TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann. Neurol. 2009;65:470&#x2013;473. doi: 10.1002/ana.21612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21612</ArticleId><ArticleId IdType="pubmed">19350673</ArticleId></ArticleIdList></Reference><Reference><Citation>White MA, et al. TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD. Nat. Neurosci. 2018;21:552&#x2013;563. doi: 10.1038/s41593-018-0113-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0113-5</ArticleId><ArticleId IdType="pmc">PMC5884423</ArticleId><ArticleId IdType="pubmed">29556029</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J, Neukomm LJ, Brown RH, Jr., Freeman MR. Age-dependent TDP-43-mediated motor neuron degeneration requires GSK3, hat-trick, and xmas-2. Curr. Biol. 2015;25:2130&#x2013;2136. doi: 10.1016/j.cub.2015.06.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2015.06.045</ArticleId><ArticleId IdType="pmc">PMC4546534</ArticleId><ArticleId IdType="pubmed">26234214</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutton M, et al. Association of missense and 5&#x2019;-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 1998;393:702&#x2013;705. doi: 10.1038/31508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/31508</ArticleId><ArticleId IdType="pubmed">9641683</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar AC, et al. The touchscreen operant platform for assessing executive function in rats and mice. Nat. Protoc. 2013;8:1985&#x2013;2005. doi: 10.1038/nprot.2013.123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2013.123</ArticleId><ArticleId IdType="pmc">PMC4131754</ArticleId><ArticleId IdType="pubmed">24051960</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim EW, et al. Optimizing reproducibility of operant testing through reinforcer standardization: identification of key nutritional constituents determining reward strength in touchscreens. Mol. Brain. 2017;10:31. doi: 10.1186/s13041-017-0312-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-017-0312-0</ArticleId><ArticleId IdType="pmc">PMC5512767</ArticleId><ArticleId IdType="pubmed">28716096</ArticleId></ArticleIdList></Reference><Reference><Citation>Heath CJ, Bussey TJ, Saksida LM. Motivational assessment of mice using the touchscreen operant testing system: effects of dopaminergic drugs. Psychopharmacology. 2015;232:4043&#x2013;4057. doi: 10.1007/s00213-015-4009-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00213-015-4009-8</ArticleId><ArticleId IdType="pmc">PMC4600476</ArticleId><ArticleId IdType="pubmed">26156636</ArticleId></ArticleIdList></Reference><Reference><Citation>Heath CJ, Phillips BU, Bussey TJ, Saksida LM. Measuring motivation and reward-related decision making in the rodent operant touchscreen system. Curr. Protoc. Neurosci. 2016;74:8 34 31&#x2013;20. doi: 10.1002/0471142301.ns0834s74.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471142301.ns0834s74</ArticleId><ArticleId IdType="pubmed">26729033</ArticleId></ArticleIdList></Reference><Reference><Citation>Hailwood, J. M. et al. Blockade of muscarinic acetylcholine receptors facilitates motivated behaviour and rescues a model of antipsychotic-induced amotivation. Neuropsychopharmacology44, 1068&#x2013;1075 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6397643</ArticleId><ArticleId IdType="pubmed">30478410</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips BU, Heath CJ, Ossowska Z, Bussey TJ, Saksida LM. Optimisation of cognitive performance in rodent operant (touchscreen) testing: evaluation and effects of reinforcer strength. Learn Behav. 2017;45:252&#x2013;262. doi: 10.3758/s13420-017-0260-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.3758/s13420-017-0260-7</ArticleId><ArticleId IdType="pmc">PMC5565648</ArticleId><ArticleId IdType="pubmed">28205186</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward RD, Simpson EH, Kandel ER, Balsam PD. Modeling motivational deficits in mouse models of schizophrenia: behavior analysis as a guide for neuroscience. Behav. Process. 2011;87:149&#x2013;156. doi: 10.1016/j.beproc.2011.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beproc.2011.02.004</ArticleId><ArticleId IdType="pmc">PMC3085964</ArticleId><ArticleId IdType="pubmed">21338658</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman, E. &amp; Winder, S. J. A modified wire hanging apparatus for small animal muscle function testing. PLoS Curr.8,10.1371/currents.md.1e2bec4e78697b7b0ff80ea25a1d38be (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5596413</ArticleId><ArticleId IdType="pubmed">28966868</ArticleId></ArticleIdList></Reference><Reference><Citation>Graybeal C, et al. Paradoxical reversal learning enhancement by stress or prefrontal cortical damage: rescue with BDNF. Nat. Neurosci. 2011;14:1507&#x2013;1509. doi: 10.1038/nn.2954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2954</ArticleId><ArticleId IdType="pmc">PMC3389817</ArticleId><ArticleId IdType="pubmed">22057192</ArticleId></ArticleIdList></Reference><Reference><Citation>Brigman JL, et al. Impaired discrimination learning in mice lacking the NMDA receptor NR2A subunit. Learn Mem. 2008;15:50&#x2013;54. doi: 10.1101/lm.777308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/lm.777308</ArticleId><ArticleId IdType="pmc">PMC3575092</ArticleId><ArticleId IdType="pubmed">18230672</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim J, et al. Assessment of mGluR5 KO mice under conditions of low stress using a rodent touchscreen apparatus reveals impaired behavioural flexibility driven by perseverative responses. Mol. Brain. 2019;12:37. doi: 10.1186/s13041-019-0441-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-019-0441-8</ArticleId><ArticleId IdType="pmc">PMC6458840</ArticleId><ArticleId IdType="pubmed">30971312</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips BU, Lopez-Cruz L, Saksida LM, Bussey TJ. Translational tests involving non-reward: methodological considerations. Psychopharmacology. 2019;236:449&#x2013;461. doi: 10.1007/s00213-018-5062-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00213-018-5062-x</ArticleId><ArticleId IdType="pmc">PMC6373191</ArticleId><ArticleId IdType="pubmed">30306228</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamone JD, Yohn SE, Lopez-Cruz L, San Miguel N, Correa M. Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology. Brain. 2016;139:1325&#x2013;1347. doi: 10.1093/brain/aww050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww050</ArticleId><ArticleId IdType="pmc">PMC5839596</ArticleId><ArticleId IdType="pubmed">27189581</ArticleId></ArticleIdList></Reference><Reference><Citation>Quirk GJ, Mueller D. Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology. 2008;33:56&#x2013;72. doi: 10.1038/sj.npp.1301555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.npp.1301555</ArticleId><ArticleId IdType="pmc">PMC2668714</ArticleId><ArticleId IdType="pubmed">17882236</ArticleId></ArticleIdList></Reference><Reference><Citation>Snowden JS, et al. Distinct behavioural profiles in frontotemporal dementia and semantic dementia. J. Neurol. Neurosurg. Psychiatry. 2001;70:323&#x2013;332. doi: 10.1136/jnnp.70.3.323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.70.3.323</ArticleId><ArticleId IdType="pmc">PMC1737271</ArticleId><ArticleId IdType="pubmed">11181853</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters F, et al. Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia. Dement Geriatr. Cogn. Disord. 2006;21:373&#x2013;379. doi: 10.1159/000091898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000091898</ArticleId><ArticleId IdType="pubmed">16534207</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry DC, et al. Reward deficits in behavioural variant frontotemporal dementia include insensitivity to negative stimuli. Brain. 2017;140:3346&#x2013;3356. doi: 10.1093/brain/awx259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx259</ArticleId><ArticleId IdType="pmc">PMC5841034</ArticleId><ArticleId IdType="pubmed">29053832</ArticleId></ArticleIdList></Reference><Reference><Citation>Pekkala S, Albert ML, Spiro A, 3rd, Erkinjuntti T. Perseveration in Alzheimer&#x2019;s disease. Dement Geriatr. Cogn. Disord. 2008;25:109&#x2013;114. doi: 10.1159/000112476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000112476</ArticleId><ArticleId IdType="pubmed">18075249</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry DC, et al. Anatomical correlates of reward-seeking behaviours in behavioural variant frontotemporal dementia. Brain. 2014;137:1621&#x2013;1626. doi: 10.1093/brain/awu075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu075</ArticleId><ArticleId IdType="pmc">PMC4032100</ArticleId><ArticleId IdType="pubmed">24740987</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeley WW, et al. Dissociable intrinsic connectivity networks for salience processing and executive control. J. Neurosci. 2007;27:2349&#x2013;2356. doi: 10.1523/JNEUROSCI.5587-06.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5587-06.2007</ArticleId><ArticleId IdType="pmc">PMC2680293</ArticleId><ArticleId IdType="pubmed">17329432</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, et al. Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer&#x2019;s disease. Brain. 2010;133:1352&#x2013;1367. doi: 10.1093/brain/awq075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awq075</ArticleId><ArticleId IdType="pmc">PMC2912696</ArticleId><ArticleId IdType="pubmed">20410145</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuen GS, et al. The salience network in the apathy of late-life depression. Int. J. Geriatr. Psychiatry. 2014;29:1116&#x2013;1124. doi: 10.1002/gps.4171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.4171</ArticleId><ArticleId IdType="pmc">PMC4197060</ArticleId><ArticleId IdType="pubmed">24990625</ArticleId></ArticleIdList></Reference><Reference><Citation>Day GS, et al. Salience network resting-state activity: prediction of frontotemporal dementia progression. JAMA Neurol. 2013;70:1249&#x2013;1253..</Citation><ArticleIdList><ArticleId IdType="pubmed">23959214</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy R, Dubois B. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb. Cortex. 2006;16:916&#x2013;928. doi: 10.1093/cercor/bhj043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhj043</ArticleId><ArticleId IdType="pubmed">16207933</ArticleId></ArticleIdList></Reference><Reference><Citation>Massimo L, Evans LK. Differentiating subtypes of apathy to improve person-centered care in frontotemporal degeneration. J. Gerontol. Nurs. 2014;40:58&#x2013;65. doi: 10.3928/00989134-20140827-01.</Citation><ArticleIdList><ArticleId IdType="doi">10.3928/00989134-20140827-01</ArticleId><ArticleId IdType="pmc">PMC4281275</ArticleId><ArticleId IdType="pubmed">25199154</ArticleId></ArticleIdList></Reference><Reference><Citation>Massimo L, et al. Apathy in frontotemporal degeneration: neuroanatomical evidence of impaired goal-directed behavior. Front Hum. Neurosci. 2015;9:611. doi: 10.3389/fnhum.2015.00611.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2015.00611</ArticleId><ArticleId IdType="pmc">PMC4639601</ArticleId><ArticleId IdType="pubmed">26617508</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed RM, et al. Quantifying the eating abnormalities in frontotemporal dementia. JAMA Neurol. 2014;71:1540&#x2013;1546. doi: 10.1001/jamaneurol.2014.1931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.1931</ArticleId><ArticleId IdType="pubmed">25329012</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolley JD, et al. Binge eating is associated with right orbitofrontal-insular-striatal atrophy in frontotemporal dementia. Neurology. 2007;69:1424&#x2013;1433. doi: 10.1212/01.wnl.0000277461.06713.23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000277461.06713.23</ArticleId><ArticleId IdType="pubmed">17909155</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman S, Sahakian BJ, Hodges JR, Rogers RD, Robbins TW. Specific cognitive deficits in mild frontal variant frontotemporal dementia. Brain. 1999;122:1469&#x2013;1493. doi: 10.1093/brain/122.8.1469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/122.8.1469</ArticleId><ArticleId IdType="pubmed">10430832</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H, Ahrlund-Richter S, Wang X, Deisseroth K, Carlen M. Prefrontal parvalbumin neurons in control of attention. Cell. 2016;164:208&#x2013;218. doi: 10.1016/j.cell.2015.11.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.11.038</ArticleId><ArticleId IdType="pmc">PMC4715187</ArticleId><ArticleId IdType="pubmed">26771492</ArticleId></ArticleIdList></Reference><Reference><Citation>Bissonette GB, Schoenbaum G, Roesch MR, Powell EM. Interneurons are necessary for coordinated activity during reversal learning in orbitofrontal cortex. Biol. Psychiatry. 2015;77:454&#x2013;464. doi: 10.1016/j.biopsych.2014.07.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2014.07.023</ArticleId><ArticleId IdType="pmc">PMC4312743</ArticleId><ArticleId IdType="pubmed">25193243</ArticleId></ArticleIdList></Reference><Reference><Citation>Nithianantharajah J, et al. Synaptic scaffold evolution generated components of vertebrate cognitive complexity. Nat. Neurosci. 2013;16:16&#x2013;24. doi: 10.1038/nn.3276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3276</ArticleId><ArticleId IdType="pmc">PMC4131247</ArticleId><ArticleId IdType="pubmed">23201973</ArticleId></ArticleIdList></Reference><Reference><Citation>Nithianantharajah J, et al. Bridging the translational divide: identical cognitive touchscreen testing in mice and humans carrying mutations in a disease-relevant homologous gene. Sci. Rep. 2015;5:14613. doi: 10.1038/srep14613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep14613</ArticleId><ArticleId IdType="pmc">PMC4589696</ArticleId><ArticleId IdType="pubmed">26423861</ArticleId></ArticleIdList></Reference><Reference><Citation>Berridge KC, Robinson TE. Parsing reward. Trends Neurosci. 2003;26:507&#x2013;513. doi: 10.1016/S0166-2236(03)00233-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0166-2236(03)00233-9</ArticleId><ArticleId IdType="pubmed">12948663</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>